Biography and Research Information
OverviewAI-generated summary
Megan Shirey's research focuses on the clinical application and effects of therapeutic agents, with a particular interest in immunoconjugates and their impact on specific diseases. Her work includes investigating the corneal toxicity associated with belantamab mafodotin, a treatment used for multiple myeloma. Shirey has also examined findings from a statewide teleretina diabetic retinopathy screening program in Arkansas, indicating an interest in the application of medical technology and screening programs for disease management.
Her scholarly output includes two publications with a total of 17 citations, and she holds an h-index of 2. Shirey collaborates with researchers at the University of Arkansas for Medical Sciences, including Sharmilan Thanendrarajan, Jaskirat Sethi, Samer Al Hadidi, and Carolina Schinke, with whom she shares publications. Her recent activity confirms her ongoing engagement in research.
Metrics
- h-index: 2
- Publications: 2
- Citations: 18
Selected Publications
-
Findings from a Statewide Teleretina Diabetic Retinopathy Screening Program in Arkansas (2023)
-
Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience (2022)
Collaboration Network
Top Collaborators
Meera Mohan
Medical College of Wisconsin (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Lisa Rein
Medical College of Wisconsin (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Nishanth Thalambedu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Yetunde Ogunsesan
University of Arkansas for Medical Sciences (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Munawwar Hussain
Winthrop Rockefeller Foundation
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Jaskirat Sethi
Winthrop Rockefeller Foundation
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Fatima Khan
University of Arkansas for Medical Sciences (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Sravani Gundarlapalli
Winthrop Rockefeller Foundation
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Lakshmi Yarlagadda
Winthrop Rockefeller Foundation (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Binod Dhakal
Medical College of Wisconsin (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Mary Price
University of Arkansas for Medical Sciences
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
David Warner
University of Arkansas for Medical Sciences (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
1 shared publication
In database
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Siegfried Janz
Froedtert Hospital (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Sabarinath Venniyil Radhakrishnan
Froedtert Hospital (US)
1 shared publication
- Corneal toxicity with belantamab mafodotin: Multi‐institutional <scp>real‐life</scp> experience
Similar Researchers
Based on overlapping research topics
Mary Price
University of Arkansas for Medical Sciences
Monoclonal and Polyclonal Antibodies Research
Pharmacological Effects and Toxicity Studies
Multiple Myeloma Research and Treatments
Asis Shrestha
University of Arkansas for Medical Sciences
Monoclonal and Polyclonal Antibodies Research
Pharmacological Effects and Toxicity Studies
Multiple Myeloma Research and Treatments
Abdul Rafae
University of Arkansas for Medical Sciences
Monoclonal and Polyclonal Antibodies Research
Pharmacological Effects and Toxicity Studies
Multiple Myeloma Research and Treatments
Michelle Robeson
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Kayla Hefner
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Manozna Karri
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Multiple Myeloma Research and Treatments
Telemedicine and Telehealth Implementation